Literature DB >> 8821902

Continuous infusion of vasopressin in comatose children with neurogenic diabetes insipidus.

Y J Lee1, E Y Shen, F Y Huang, H A Kao, S D Shyur.   

Abstract

Three comatose children with neurogenic diabetes insipidus were treated with intravenous infusion of vasopressin. The infusion of vasopressin was started at a dose of 1.3 to 2.7 mU/kg/h as soon as diabetes insipidus was diagnosed. The effect (urine flow < 2 ml/kg/h with increased specific gravity) was noted in 1 to 6 hours. The infusion rate of vasopressin was adjusted according to urine flow rate which was usually kept around 65 ml/100 kcal metabolized/day. Hypernatremia was corrected 17 to 53 hours after the initiation of infusion of vasopressin. The levels of sodium stayed between 127 and 151 mmol/l during a period of 2.5 to 22 days until the patients' death due to the termination of respiratory support or cardiac decompensation. A continuous infusion of vasopressin offered the advantage of rapid onset and termination of effect and therefore could be easily titrated. It seems a rational therapy for comatose children with neurogenic diabetes insipidus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821902     DOI: 10.1515/jpem.1995.8.4.257

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  1 in total

1.  CENTRAL DIABETES INSIPIDUS AND CHEMOTHERAPY: USE OF A CONTINUOUS ARGININE VASOPRESSIN INFUSION FOR FLUID AND SODIUM BALANCE.

Authors:  Joshua A Levine; Susan L Karam; Clare O'Connor; Smita Kumar; Malini Soundarrajan; Deepika McConnell; Abeer T Ammar; Ashley M Gale; Donald Zimmerman; Emily D Szmuilowicz
Journal:  AACE Clin Case Rep       Date:  2018 Nov-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.